Supplier Product Identification Physical and Chemical Properties First Aid Measures Handling and Storage Hazards Identification Exposure Controls/Personal Protection Fire Fighting Measures Accidental Release Measures Stability and Reactivity
Home > Suramin sodium > Suramin sodium(129-46-4)

Suramin sodium(129-46-4)

Supplier Product Identification Physical and Chemical Properties First Aid Measures Handling and Storage Hazards Identification Exposure Controls/Personal Protection Fire Fighting Measures Accidental Release Measures Stability and Reactivity
More
Less

Product Identification

Product Name

Suramin sodium

Synonyms

8-[[4-Methyl-3-[[3-[[3-[[2-methyl-5-[(4,6,8-trisulfonaphthalen-1-yl)carbamoyl]phenyl]carbamoyl]phenyl]carbamoylamino]benzoyl]amino]benzoyl]amino]naphthalene-1,3,5-trisulfonic acid
Bayer 205
Germanin
Moranyl
Naganine
Naphuride sodium

CAS

129-46-4

Formula

C51H34N6Na6O23S6

Molecular Weight

1429.15

EINECS

204-949-3

RTECS

QM7000000

RTECS Class

Drug

Merck

12,9181

Beilstein/Gmelin

3694087

More
Less

Physical and Chemical Properties

Appearance

White powder.

Usage

A primary agent in the treatment of african sleeping sickness.

More
Less

First Aid Measures

Ingestion

Get medical aid. Wash mouth out with water.

Inhalation

Remove from exposure to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.

Skin

Get medical aid. Flush skin with plenty of soap and water for at least 15 minutes while removing contaminated clothing and shoes.

Eyes

Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.

More
Less

Handling and Storage

Storage

Store in a cool, dry place. Store in a tightly closed container. Refrigerator (approx 4 C).

Handling

Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.

More
Less

Hazards Identification

Ingestion

May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.

Inhalation

May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.

Skin

May cause skin irritation.

Eyes

May cause eye irritation.

More
Less

Exposure Controls/Personal Protection

Personal Protection

Skin: Wear appropriate protective gloves to prevent skin exposure. Clothing: Wear appropriate protective clothing to prevent skin exposure.

Respirators

Follow the OSHA respirator regulations found in 29CFR 1910.134 or European Standard EN 149. Always use a NIOSH or European Standard EN 149 approved respirator when necessary.

More
Less

Fire Fighting Measures

Fire Fighting

Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. To extinguish fire use water spray, dry chemical, carbon dioxide, or chemical foam.

More
Less

Accidental Release Measures

Small spills/leaks

Vacuum or sweep up material and place into a suitable disposal container.

More
Less

Stability and Reactivity

Stability

No data.

Incompatibilities

Strong oxidizing agents.

Decomposition

Nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide, sodium oxide.

More
Less

ContactMore

Guangzhou Astrazeneca Pharmaceutical Co. LTD
WebSite
https://www.chemicalbook.com/ShowSupplierProductsList1931076/0_EN.htm
MedBioPharmaceutical Technology Inc
Tel
021-69568360
WebSite
http://www.med-bio.cn/
Shanghai Xuerong Chemical Technology Co., LTD
Fax
QQ:230497258
WebSite
https://www.chemicalbook.com/ShowSupplierProductsList717026/0_EN.htm
Jinan Mingwei PharmTech Co.,LTD
Tel
0538-5352278
WebSite
https://www.mwpharmtech.com
Shanghai Fine Biotech Co.,Ltd
Tel
18221172427;
WebSite
https://www.fine-biotech.com